Brind.
  1. Medicus Pharma Ltd., a biotech company based in the US, has received the FDA's acceptance of its Type C meeting request.

Andrew Smith was appointed Chief Operating Officer of Medicus Pharma Ltd. on June 23, 2025.

1 report, 0 independent Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Andrew Smith was appointed Chief Operating Officer of Medicus Pharma Ltd. on June 23, 2025.

Who's involved

What this event is mainly about
Andrew Smith

Keep exploring

Part of

Medicus Pharma Ltd., a biotech company based in the US, has received the FDA's acceptance of its Type C meeting request. All 1 developments

The entities involved

  • Andrew Smith

    researcher (ORCID 0000-0001-6007-2389)

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • Unknown outlet